BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 17, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New Jersey

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy

Veterans

Issues related to veteran's care and veteran's reproductive care

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.